Impact of Thrombocytopenia on Survival in Patients with Hepatocellular Carcinoma: Updated Meta-Analysis and Systematic Review
Cancers · 27.03.2024 · 16 (7) · 1293
DOI: 10.3390/cancers16071293 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 27.03.2024. Verfasst von Leszek Kraj und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, University Clinical Centre, Medical University of Warsaw, 02-091 Warsaw, Poland. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Platelets (PLT) have a role in the pathogenesis, progression, and prognosis of hepatocellular carcinoma (HCC) and could represent a readily measurable laboratory parameter to enhance the comprehensive evaluation of HCC patients.
Methods
The PubMed, Web of Science, and Scopus databases were searched with a focus on survival as well as patient and tumor-specific characteristics in correlation to reported PLT counts. Survival outcomes were analyzed with both common-effect and random-effects models. The hazard ratio (HR) and its 95% confidence interval (CI) from analyzed trials were incorporated. Studies that did not provide survival data but focused on platelet count correlation with HCC characteristics were reviewed.
Results
In total, 26 studies, including a total of 9403 patients, met our criteria. The results showed that thrombocytopenia in HCC patients was associated with poor overall survival (common-effect HR = 1.15, 95% CI: 1.06–1.25; random-effect HR = 1.30, 95% CI: 1.05–1.63). Moreover, three studies reveal significant correlations between PLT indices and tumor characteristics such as size, foci number, and etiology of HCC development.
Conclusion
Our meta-analysis confirmed that PLT count could act as a prognostic marker in HCC, especially with a PLT count cut off
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, University Clinical Centre, Medical University of Warsaw, 02-091 Warsaw, Poland.
- Department of Molecular Biology, Institute of Genetics and Animal Biotechnology, Polish Academy of Science, 01-447 Magdalenka, Poland.
- University Clinical Centre, Medical University of Warsaw, 02-091 Warsaw, Poland.
- 2nd Department of Clinical Radiology, University Clinical Centre, Medical University of Warsaw, 02-091 Warsaw, Poland.
- Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL 32224, USA.
ORCID-Profile: Paulina Chmiel, Łukasz Szymański
Zitieren
APA
Kraj, L., Chmiel, P., Gryziak, M., Grabowska-Derlatka, L., Szymański, Ł., & Wysokińska, E. (2024). Impact of Thrombocytopenia on Survival in Patients with Hepatocellular Carcinoma: Updated Meta-Analysis and Systematic Review. Cancers, 16(7), 1293. https://doi.org/10.3390/cancers16071293
Vancouver
Kraj L, Chmiel P, Gryziak M, Grabowska-Derlatka L, Szymański Ł, Wysokińska E. Impact of Thrombocytopenia on Survival in Patients with Hepatocellular Carcinoma: Updated Meta-Analysis and Systematic Review. Cancers. 2024;16(7):1293. doi:10.3390/cancers16071293
BibTeX
@article{Kraj2024,
author = {Kraj, Leszek and Chmiel, Paulina and Gryziak, Maciej and Grabowska-Derlatka, Laretta and Szymański, Łukasz and Wysokińska, Ewa},
title = {Impact of Thrombocytopenia on Survival in Patients with Hepatocellular Carcinoma: Updated Meta-Analysis and Systematic Review},
journal = {Cancers},
year = {2024},
volume = {16},
number = {7},
pages = {1293},
doi = {10.3390/cancers16071293}
}
EUVIMED